chartexchange

EYPT
EyePoint, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:04:52 PM EST
0.27USD-2.390%(-0.01)2,080,315
Pre-marketNov 19, 2026 9:28:30 AM EST
0.2747USD+0.993%(+0.0027)
0.2700Bid0.2700Ask0.0000Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Watertown, MA, USA
Previous Close
$0.27
Beta
1.28
52-Week High
$19.11 2025-12-08
52-Week Low
$0.27 2026-11-18
SMA 50
$2.07
SMA 200
$10.04
Avg. Vol 10D
4.97M
Avg. Vol 30D
13.80M
Avg. Vol 90D
7.34M
Relative Vol
0.15
113.78M
97.67M
11,020,929
0.4200%
6,900,000
5,802
2,488,651
9,940,990
Dec 9, 2020 · 1-for-10 (reverse)
EYPT Profile

psivida corp., (nasdaq: psdv) (asx: pva) headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. psivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, durasert™ and biosilicon™. the injectable, sustained release micro-insert iluvien® for the treatment of chronic diabetic macula edema (dme), licensed to alimera sciences, inc., has received marketing authorization in austria, france, germany, portugal, the u.k. spain, and italy. iluvien for dme has recently been approved in the us. psivida plans to institute pivotal phase iii clinical trials for the treatment of posterior uveitis with the same micro-insert as iluvien for dme. an investigator-sponsored clinical trial is ongoing for an injectable, bioerodible micro-insert to treat glaucoma and ocular hypertension. psivida's two fda-approved products, retisert®

EYPT Performance
PeriodPriceDateChangeBeta
1W0.322026-11-12-16.90%-4.257
1M0.442026-10-19-39.66%0.888
3M6.302026-08-19-95.79%0.942
6M11.822026-05-19-97.75%1.089
1Y14.282025-11-19-98.14%1.277
2Y9.212024-11-19-97.12%—
5Y17.242021-11-19-98.46%1.130
EYPT Stock Summary

EyePoint, Inc. Common Stock (NASDAQ:EYPT) stock price today is $0.27, and today's volume is 2,014,139. EYPT is down 2.390% today. The 30 day average volume is 13.80M. EYPT market cap is $30.21M with 113.78M shares outstanding.